Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AVPR2 | P30518 | 17/20 | 0.55 |
| ▸ | AVPR1A | P37288 | 5/20 | 0.50 |
| ▸ | OXTR | P30559 | 1/20 | 0.50 |
| ▸ | AVPR1B | P47901 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6965944 | 0.88 | AVPR2 (0.57) | AVPR2AVPR1AOXTRAVPR1B | |
| SCHEMBL6964360 | 0.85 | AVPR2 (0.60) | AVPR2AVPR1AOXTR | |
| SCHEMBL6971545 | 0.82 | AVPR2 (0.68) | AVPR2AVPR1AOXTRAVPR1B | |
| SCHEMBL6701281 | 0.80 | AVPR2 (0.56) | AVPR2AVPR1AOXTRAVPR1B | |
| SCHEMBL8961671 | 0.79 | AVPR2 (0.61) | AVPR2AVPR1AOXTRAVPR1B | |
| SCHEMBL8961674 | 0.79 | AVPR2 (0.61) | AVPR2AVPR1AOXTRAVPR1B | |
| SCHEMBL6965665 | 0.79 | AVPR2 (0.53) | AVPR2AVPR1AOXTRAVPR1B | |
| SCHEMBL6965024 | 0.79 | AVPR2 (0.57) | AVPR2AVPR1AOXTRAVPR1B | |
| SCHEMBL6966950 | 0.79 | AVPR2 (0.52) | AVPR2AVPR1AOXTRAVPR1B | |
| SCHEMBL6970694 | 0.79 | AVPR2 (0.52) | AVPR2AVPR1AOXTRAVPR1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0620216-B1 | Benzamide derivatives and their use as vasopressin antagonists | FUJISAWA PHARMACEUTICAL CO (JP) | 2003-01-08 | — | — | EP | disclosed |
| EP-0620216-A1 | Benzamide derivatives and their use as vasopressin antagonists | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1994-10-19 | — | — | EP | disclosed |